Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
EHA 2023, 2023
In this review article, we first describe the recent epidemiological and mechanistic evidences linking environmental/occupational exposures with various ADs (especially SLE)
Over time, this may lead to needing higher doses to achieve the same outcome or cause a suppressed natural output interval upon discontinuing therapy
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance
Oxidative stress: fundamentals and advances in quantification techniques
Discrepant outcomes from earlier studies, largely attributable to small sample sizes and variations in primary endpoints and vitamin E formulations, have contributed to this cautious stance
US$ 26.98
US$ 29.43
US$ 29.34
US$ 26.78
US$ 29.66
